Patents by Inventor Bryan Walser

Bryan Walser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20180042816
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: October 24, 2017
    Publication date: February 15, 2018
    Inventors: Bryan WALSER, Howard V. RAFF
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20170021012
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: September 26, 2016
    Publication date: January 26, 2017
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • Peanut formulations and uses thereof
    Patent number: 9492535
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: November 15, 2016
    Assignee: AIMMUNE THERAPEUTICS, INC.
    Inventors: Bryan Walser, Howard V. Raff
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20160030289
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: October 13, 2015
    Publication date: February 4, 2016
    Inventors: Bryan WALSER, Howard V. RAFF
  • Manufacture of peanut formulations for oral desensitization
    Patent number: 9198869
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: December 1, 2015
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20140271836
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: Allergen Research Corporation
    Inventors: Bryan Walser, Howard V. Raff
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20140271721
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: Allergen Research Corporation
    Inventors: Bryan Walser, Howard V. Raff
  • METHODS FOR BREAST CANCER RISK ASSESSMENT
    Publication number: 20110294681
    Abstract: The present invention relates to methods and systems for assessing the overall risk of a human female subject for developing a breast cancer phenotype. In particular, the present invention relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.
    Type: Application
    Filed: June 1, 2010
    Publication date: December 1, 2011
    Inventors: David A. Hinds, Bryan Walser
  • Prediction markets for assessing clinical probabilities of success
    Publication number: 20070250429
    Abstract: Prediction markets are used to determine the probability of an experimental therapeutic, diagnostic, or prophylactic candidate meeting clinical trial and post-trial goals, such as clinical trial endpoints and timelines. The prediction market processes buy and sell orders from market participants, while adjusting the prices of the securities according to the orders. The securities have specific meanings which correspond to goals in clinical trials or other outcomes in clinical candidate development. The price of a security determined by the market corresponds to the probability of the corresponding goal or outcome. The participants are selected for their expert knowledge of specific factors related to candidate development.
    Type: Application
    Filed: April 19, 2006
    Publication date: October 25, 2007
    Applicant: Clinical Futures LLC
    Inventors: Bryan Walser, Marc Elia